HCV Patient Care for the Non-Hepatologist: Management of Chronic HCV in the Era of Protease Inhibitors

With an increasing demand for HCV care in the U.S.and not enough hepatologists to meet this demand — especially outside of larger metropolitan areas — general practce gastroenterologists are needed to help fill the gap. This webinar is intended to help  enhance their ability to effectively and efficiently treat most HCV-positive patients.

It will also be valuable to all clinicians since it addresses the changes in treatment and expected outcomes of the direct-acting drugs telapravir and boceprevir. Additional topics to be covered, but not limited to, will include:

  • Epidemiology and natural history of HCV infection.
  • Screening and diagnosis of HCV, including genotypes and implications for treatment.
  • Selecting and dosing treatment options.
  • Identifying and managing treatment side effects and assessing treatment success.
  • Treatment failures.
  • Cost-efficient patient management.
  • Co-morbidities.

This webinar is part two of a two-part series. Click here to view the first webinar.

Target Audience

Gastroenterologists, physician assistants, nurse practitioners, trainees

Course Director and Faculty

Course Director

Vinod K. Rustgi, MD
Medical Director, Liver Transplantation
Metropolitan Liver Diseases/Gastroenterology Center
Fairfax, VA

Faculty

Stuart C. Gordon, MD
Director of Hepatology
Henry Ford Hospital
Detroit, MI

K. Rajender Reddy, MD
Professor of Medicine
Director of Hepatology
Hospital of the University of Pennsylvania
Philadelphia, PA

Faculty Disclosures

Stuart C. Gordon - Advisory Committees or Review Panels: Merck & Co, Gilead Sciences Inc; Consulting: Achillion Pharmaceutical, CVS-Caremark; Speaking and Teaching: Merck & Co, Gilead Sciences Inc, Vertex Pharmaceuticals

K. Rajender Reddy - Advisory Committees or Review Panels: Roche Pharma AG, Gilead Sciences Inc, Vertex Pharmaceuticals , Merck & Co, Tibotec
 
Vinod K. Rustgi - Consulting: Vertex, Merck; Grant/Research Support: Anadys , Genentech, Schering-Plough Corp., Bristol-Myers Squibb Co. , Abbott Labs, Boehringer-Ingelheim; Speaking and Teaching: OnyxPharmaceuticals , Roche
 
AGA Staff and planning committee have no relationships to disclose.

Additional Information

For for questions related to the webinar, contact Sandra Megally at smegally@gastro.org.

0 out of 0 users found this page helpful.

Was this page helpful?